Advanced Search Results For "De Girolamo, Micaela"
Your filters
Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study
Publication Type: Academic Journal
Source(s): Respiratory Research, Vol 24, Iss 1, Pp 1-13 (2023)
Abstract: Abstract Background The efficacy of benralizumab has been broadly demonstrated in severe eosinophilic asthma (SEA), but only few real-life studies evaluated its long-term effects. Here we present novel data from the ANANKE study in which a large cohort...
ChAracterization of ItaliaN severe uncontrolled Asthmatic patieNts Key features when receiving Benralizumab in a real-life setting: the observational rEtrospective ANANKE study
Publication Type: Academic Journal
Source(s): Respiratory Research, Vol 23, Iss 1, Pp 1-13 (2022)
Abstract: Abstract Background Data from phase 3 trials have demonstrated the efficacy and safety of benralizumab in patients with severe eosinophilic asthma (SEA). We conducted a real-world study examining the baseline characteristics of a large SEA population t...
Switching from one biologic to benralizumab in patients with severe eosinophilic asthma: An ANANKE study post hoc analysis
Publication Type: Academic Journal
Source(s): Frontiers in Medicine, Vol 9 (2022)
Abstract: BackgroundSevere asthma is a heterogeneous inflammatory disease driven by eosinophilic inflammation in the majority of cases. Despite biologic therapy patients may still be sub-optimally controlled, and the choice of the best biologic is a matter of de...
Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis
Publication Type: Academic Journal
Source(s): Frontiers in Allergy, Vol 3 (2022)
Abstract: BackgroundSevere eosinophilic asthma (SEA) in the presence of chronic rhinosinusitis with nasal polyps (CRSwNP) indicates the presence of a more extensive eosinophilic inflammation. Post-hoc analyses from a pivotal clinical trial have demonstrated the ...
Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study.
Publication Type: Academic Journal
Source(s): Respiratory Research; 5/20/2023, Vol. 24 Issue 1, p1-13, 13p
Abstract: Copyright of Respiratory Research is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or...
In Vitro and In Vivo Pharmaco-Toxicological Characterization of 1-Cyclohexyl-x-methoxybenzene Derivatives in Mice: Comparison with Tramadol and PCP
Publication Type: Academic Journal
Source(s): International Journal of Molecular Sciences, Vol 22, Iss 14, p 7659 (2021)
Abstract: 1-cyclohexyl-x-methoxybenzene is a novel psychoactive substance (NPS), first discovered in Europe in 2012 as unknown racemic mixture of its three stereoisomers: ortho, meta and para. Each of these has structural similarities with the analgesic tramadol...
Inter-Organelle Contact Sites Mediate the Intracellular Antioxidant Activity of Platinum Nanozymes: A New Perspective on Cell–Nanoparticle Interaction and Signaling.
Publication Type: Academic Journal
Source(s): ACS Applied Materials & Interfaces; 2/1/2023, Vol. 15 Issue 4, p3882-3893, 12p
Clinical Features and Efficacy of Benralizumab in Patients with Blood Eosinophil Count Between 300 and 450 Cells/mm3: A Post Hoc Analysis from the ANANKE Study.
Publication Type: Academic Journal
Source(s): Journal of Asthma & Allergy; Nov2022, Vol. 15, p1593-1604, 12p
Abstract: Copyright of Journal of Asthma & Allergy is the property of Dove Medical Press Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may prin...
ChAracterization of ItaliaN severe uncontrolled Asthmatic patieNts Key features when receiving Benralizumab in a real-life setting: the observational rEtrospective ANANKE study.
Publication Type: Academic Journal
Source(s): Respiratory Research; 2/19/2022, Vol. 23 Issue 1, p1-13, 13p
Abstract: Copyright of Respiratory Research is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or...
In Vitro and In Vivo Pharmaco-Toxicological Characterization of 1-Cyclohexyl-x-methoxybenzene Derivatives in Mice: Comparison with Tramadol and PCP.
Publication Type: Academic Journal
Source(s): International Journal of Molecular Sciences; Jul2021, Vol. 22 Issue 14, p7659-7659, 1p
Abstract: Copyright of International Journal of Molecular Sciences is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print,...